Serum-soluble CD4 as clinical and immunological marker in patients with dilated cardiomyopathy.
暂无分享,去创建一个
G. Kramer | M. Péč | G. Mundigler | R. Pacher | R. Ullrich | M. Mehrabi | M. Imhof | K. Plesch | G. Klappacher | W. Kukutschki
[1] D. Fuchs,et al. Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis. , 1992, Clinical chemistry.
[2] D. Fuchs,et al. Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. , 1992, Immunology letters.
[3] G. Schreiner,et al. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. , 1990, Circulation research.
[4] H. Fillit,et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.
[5] E. Bonifacio,et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? , 1990, Journal of autoimmunity.
[6] S. Cobbe,et al. Study of serum C-reactive protein concentration in cardiac failure. , 1990, British heart journal.
[7] H. Schultheiss,et al. Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. , 1990, Circulation.
[8] C. Limas,et al. HLA antigens in idiopathic dilated cardiomyopathy. , 1989, British heart journal.
[9] M. Kahaleh,et al. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. , 1989, Annals of internal medicine.
[10] H. Schultheiss,et al. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. , 1989, Circulation research.
[11] John Sanderson. Suppressor T lymphocyte function in patients with idiopathic congestive cardiomyopathy , 1988, British heart journal.
[12] R. Colvin,et al. Plasma interleukin 2 receptor levels in renal allograft recipients. , 1987, Clinical immunology and immunopathology.
[13] N. Bowles,et al. DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.
[14] H. Schultheiss,et al. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. , 1985, Journal of molecular and cellular cardiology.
[15] J. Carlquist,et al. Quantitation of lymphocyte subsets by immunofluorescence flow cytometry in idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.
[16] J. Sanderson,et al. T-lymphocyte subsets in idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.
[17] B. Maisch,et al. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. , 1983, The American journal of cardiology.
[18] D. Glogar,et al. Elevated circulating levels of beta 2-microglobulin in patients with idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.
[19] I. Goldenberg,et al. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. , 1989, Circulation research.